Your browser doesn't support javascript.
loading
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study).
Yoshioka, H; Azuma, K; Yamamoto, N; Takahashi, T; Nishio, M; Katakami, N; Ahn, M J; Hirashima, T; Maemondo, M; Kim, S W; Kurosaki, M; Akinaga, S; Park, K; Tsai, C M; Tamura, T; Mitsudomi, T; Nakagawa, K.
Afiliación
  • Yoshioka H; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki hirotin@kchnet.or.jp.
  • Azuma K; Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume.
  • Yamamoto N; Third Department of Internal Medicine, Wakayama Medical University, Wakayama.
  • Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Nagaizumi.
  • Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of JFCR, Tokyo.
  • Katakami N; Division of Integrated Oncology, Institute of Biomedical Research and Innovation Hospital, Kobe, Japan.
  • Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Hirashima T; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino.
  • Maemondo M; Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan.
  • Kim SW; Department of Oncology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kurosaki M; R&D division, Kyowa Hakko Kirin Co., Ltd, Tokyo, Japan.
  • Akinaga S; R&D division, Kyowa Hakko Kirin Co., Ltd, Tokyo, Japan.
  • Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Tsai CM; Chest Department, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Tamura T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo.
  • Mitsudomi T; Departments of Thoracic Surgery.
  • Nakagawa K; Medical Oncology, Kinki University Faculty of Medicine, Osakasayama, Japan.
Ann Oncol ; 26(10): 2066-72, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26153496
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirrolidinonas / Quinolinas / Adenocarcinoma / Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Clorhidrato de Erlotinib / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirrolidinonas / Quinolinas / Adenocarcinoma / Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Clorhidrato de Erlotinib / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article